| Autor: |
Agnandji, Selidji T, Csaki Huttner, Angela, Zinser, Madeleine E, Njuguna, Patricia, Dahlke, Christine, Fernandes, José F, Yerly, Sabine, Dayer, Julie-Anne, Kraehling, Verena, Kasonta, Rahel, Adegnika, Akim A, Altfeld, Marcus, Auderset, Floriane, Bache, Emmanuel B, Biedenkopf, Nadine, Borregaard, Saskia, Brosnahan, Jessica S, Burrow, Rebekah, Combescure, Christophe, Desmeules, Jules Alexandre, Eickmann, Markus, Fehling, Sarah K, Finckh, Axel, Goncalves Cabecinhas, Ana Rita, Grobusch, Martin P, Hooper, Jay, Jambrecina, Alen, Kabwende, Anita L, Kaya, Gurkan, Kimani, Domtila, Lell, Bertrand, Lemaître, Barbara, Lohse, Ansgar W, Massinga-Loembe, Marguerite, Matthey, Alain, Mordmüller, Benjamin, Nolting, Anne, Ogwang, Caroline, Ramharter, Michael, Schmidt-Chanasit, Jonas, Schmiedel, Stefan, Silvera, Peter, Stahl, Felix R, Staines, Henry M, Strecker, Thomas, Stubbe, Hans C, Tsofa, Benjamin, Zaki, Sherif, Fast, Patricia, Moorthy, Vasee, Kaiser, Laurent, Krishna, Sanjeev, Becker, Stephan, Kieny, Marie-Paule, Bejon, Philip, Kremsner, Peter G, Addo, Marylyn M, Siegrist, Claire-Anne, VSV Ebola Consortium (VEBCON) |
| Jazyk: |
angličtina |
| Rok vydání: |
2016 |
| Předmět: |
|
| Zdroj: |
New England Journal of Medicine, Vol. 374, No 17 (2016) pp. 1647-1660 |
| ISSN: |
0028-4793 |
| Popis: |
The replication-competent recombinant vesicular stomatitis virus (rVSV)–based vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety and immunogenicity testing before its use in West Africa. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
